A Region of Homozygous Deletion on Chromosome 9p21-22 in Primary Nasopharyngeal Carcinoma

Cancer Research

Volumn 54, Issue 15, 1994, Pages 4003-4006

  Huang, Dolly P ^a   Lo, Kwok Wai ^a   Hasselt, C Andrew Van ^b   Woo, John K S ^b   Choi, Peter H K ^c   Leung, Sing Fai ^c   Cheung, Siu Tim ^a   Cairns, Paul ^d   Sidransky, David ^e   Lee, Joseph C K ^a  

^a Departments of Anatomical and Cellular Pathology ^*  (United States)

^b Division of Otorhinolaryngology   (United States)

^c Clinical Oncology ^*  (United States)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; AUTORADIOGRAPHY; CARCINOGENESIS; CHROMOSOME 9P; CHROMOSOME DELETION; CHROMOSOME MAP; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENETIC POLYMORPHISM; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; NASOPHARYNX CARCINOMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ALLELES; CARCINOMA; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; HOMOZYGOTE; HUMANS; NASOPHARYNGEAL NEOPLASMS;

EID: 0027966039     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Diaz, M.O., Rubin, C.M., Harden, A., Ziemin, S., Le Beau, R.A., and Rowley, J.D. Deletions of interferon genes in acute lymphoblastic leukemia. N. Engl. J. Med., 322: 77-82, 1990.
2. Cairns, P., Shaw, M.E., and Knowles, M.A. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9. Oncogene, 8: 1083-1085, 1993.
3. Spruck C.H., III, Ohneseit, P.F., Gonzalez, M., Esrig, D., Miyai, N., Tsai, Y.C., Lerner, S.P., Schmuutte, C., Yang, A.S., Cote, R., Dubeau, L., Nichols, P.W., Hermann, G.G., Steven, K., Horn, T., Skinner, D.G., and Jones, P.A. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res., 54: 784-788, 1994.
4. Cairns, P., Tokino, K., Eby, Y., and Sidransky, D. Homozygous deletions of 9p. 1 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res., 54: 1422-1424, 1994.
5. James, C.D., Collins, V.P., Allalunis-Turner, M.J., and Days, R.S. Localization of chromosome 9p homozygous deletions in glioma cell lines with markers constituting a continuous linkage map. Cancer Res., 53: 3674-3676, 1993.
6. Cheng, J.Q., Jhanwar, S.C., Lu, Y.Y., and Testa, J.R. Homozygous deletions within 9p. 1-p. 2 identify a small a critical region of chromosome loss in human malignant mesotheliomas. Cancer Res., 53: 4761-4763, 1993.
7. Fountain, J.W., Karayiorgou, M., Ernstoff, M.S., Kirkwood, J.M., Vlovk, D.R., Titus-Ernstoff, L., Bouchard, B., Vijayasaradhi, S., Houghton, A.N., Lahti, J., Kidd, V.J., Housman, D.E., and Dracopoli, N.C. Homozygous deletions within human chromosome band 9p. 1 in melanoma. Proc. Natl. Acad. Sci. USA, 89: 10557-10561, 1992.
8. Coleman, A., Fountain, J.W., Nobori, T., Olopade, O.I., Robertson, G., Housman, D.E., and Lugo, T.G. Distinct deletions of chromosome 9p associated with melanoma versus glioma, lung cancer, and leukemia. Cancer Res., 54: 344-348, 1994.
9. Olopade, O.I., Buchhagen, D.L., Malik, K., Sherman, J., Nobori, T., Bader, S., Nau, M.M., Gazdar, A.F., Minna, J.D., and Diaz, M.O. Homozygous loss of interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res., 53: 2410-2415, 1993.
10. Merlo, A., Gabrielson, E., Askin, F., Baylin, S., and Sidransky, D. Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res., 54: 640-642, 1994.
11. van der Riet, P., Nawroz, H., Hruban, R.H., Corio, R., Tokino, K., Koch, W., and Sidransky, D. Frequent loss of chromosome 9p. 1-22 early in head and neck cancer progression. Cancer Res., 54: 1156-1158, 1994.
12. Nawroz, H., van der Riet, P., Hruban, R.H., Koch, W., and Sidransky, D. Allelotype of head and neck squamous cell carcinoma. Cancer Res., 54: 1152-1155, 1994.
13. Huang, D.P., Ho, H.C., Henle, W., Henle, G., Saw, D. and Lui, M. Presence of EBNA in nasopharyngeal carcinoma and control patient tissues related to EBV serology. Int. J. Cancer, 22: 266-274, 1978.
14. Huang, D.P., Lo, K.W., Choi, P.H.K., Ng, A.Y.T., Tsao, S.Y., Yiu, G.K.C., and Lee, J.C.K. Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma. Cancer Genet. Cytogenet., 54: 91-99, 1991.
15. Choi, P.H.K., Suen, M.W.M., Huang, D.P., Lo, K.W. & Lee, J.C.K. Nasopharyngeal carcinoma-a genetic defect, Epstein-Barr virus infection, or both: a clinical and molecular study of 36 patients. Cancer (Phila.), 72: 2873-2878, 1993.
16. Lo, K.W., Tsao, S.W., and Huang, D.P. Detailed deletion mapping on the short arm of chromosome 3 in nasopharyngeal carcinomas. Proc. Am. Assoc. Cancer Res., 35: 571, 1994.
17. Spruck, C.H., Tsao, Y.C., Huang, D.P., Yang, A.S., Rideout W.M., Gonzalwz-Zulueta, M., Choi, P., Yu, M.C., and Jones, P.A. Absence of p. 3 gene mutations in primary nasopharyngeal carcinomas. Cancer Res., 52: 4787-4790, 1992.
18. Shanmugaratnam, K. Histological Typing of Upper Respiratory Tract Tumors, No. 19. International Histological Classification of Tumors. Geneva: WHO, 1978.
19. Maniatis, T., Fritsch, E.F., and Sambrook, J. Molecular Cloning: A Laboratory Manual, Ed. 2. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
20. Fountain, J.W., Hudson, T.J., Engelstein, M., Housman, D.E., and Dracopoli, N.C. Dinucleotide repeat polymorphism at the D9S126 locus (9p. 1). Hum. Mol. Genet., 2: 823, 1993.
21. Kwiakowski, D.J., Armour, J., Bale, A.E., Fountain, J.W., Goudle, D., Haines, J.H., Knowles, M.A., Pilz, A., Slaugenhaupt, S., and Povey, S. Report on the Second International Workshop on Human Chromosome 9. Cytogenet. Cell Genet., 64: 94-103, 1993.
22. Cooperative Human Linkage Center (CHLC) Report, Vol. 1, pg. 9. Iowa City, IA: Cooperative Human Linkage Center, University of Iowa, December 1993.
23. Serrano, M., Hannon, G.J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
24. Kamb, A., Gruis, N.A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S.V., Stockert, E., Day III, R.S., Johnson, B.E., and Skolnick, M.H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.